Search Results - "Epstein AS"

Why Newly-Released Emails 'Change Everything' And Epstein Will 'Haunt Trump From His Grave': Author.

Source: Forbes.com. 11/13/2025, pN.PAG-N.PAG. 1p.

These Major Questions About Jeffrey Epstein's Actions On Island Still Need Answers: True Crime Author Barry Levine.

Source: Forbes.com. 8/4/2025, pN.PAG-N.PAG. 1p.

What I Learned— And Questions I Still Have— From DOJ's Latest Trove Of Epstein Docs: Barry Levine.

Source: Forbes.com. 2/3/2026, pN.PAG-N.PAG. 1p.

Fibromyalgia in the Setting of Prior Epstein–Barr Virus Infection: A Case Report.

Authors: Bhattessa, Saachi Dave, Tirth Modi, Priti

Source: Clinical Case Reports. Jun2026, Vol. 14 Issue 6, p1-4. 4p.

Playing both sides – Epstein-Barr Virus accumulates select cellular transcripts to counter virus-mediated host shut-off in lytic cells.

Authors: Daigle, Derek Creasy-Marrazzo, Ashton Gradoville, Lyn et al.

Source: PLoS Pathogens. 5/11/2026, Vol. 22 Issue 5, p1-31. 31p.

Early Neurotoxicity following a Single Dose of Brentuximab in a Patient with Epstein Bar Virus Driven Lymphoma: A Case Report.

Authors: Richards, Alexandra E. Maniyar, Anuj Howrey, Richard et al.

Source: Case Reports in Oncology. Jan2026, Vol. 19 Issue 1, p270-275. 6p. 2 Illustrations.

Author's Response to Peer Reviews of "Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis".

Authors: Friedenson, Bernard

Source: JMIRx med 2025; Vol. 6.

Journal Info: Publisher: JMIR Publications Inc. ISSN: 2563-6316

Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' reply.

Authors: Nayagam JS Heneghan MA Samyn M et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Feb; Vol. 55 (3), pp. 366-367.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

How Epstein Barr virus shapes lupus autoimmunity: mechanistic insights and therapeutic perspectives.

Authors: Miskovic R Jeremic I Miljanovic D et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 02; Vol. 17, pp. 1853891. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Epstein-Barr virus associated diseases: Immune alterations and targeted approaches.

Authors: Cao S Xiong J Zhao J et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 08; Vol. 17, pp. 1794394. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma Occurring in Spleen of a Patient after Chemotherapy for Lung Carcinoma: A Case Report.

Authors: Morishige, Takushi Hirazawa, Katsutoshi Tanaka, Akira et al.

Source: Case Reports in Oncology. Jan2026, Vol. 19 Issue 1, p293-301. 9p. 4 Illustrations.

Callitrichine herpesvirus 3 in the common marmoset is a model of Epstein-Barr virus infection and associated lymphoma.

Authors: Piotrowski, Stacey L. Li, Xiaofan Fitzpatrick, Caitlin E. et al.

Source: PLoS Pathogens. 7/17/2026, Vol. 22 Issue 7, p1-22. 22p.

Spontaneous remission of Epstein-Barr virus positive diffuse large B-cell lymphoma after relapse post axicabtagene ciloleucel chimeric antigen receptor T-cell therapy.

Authors: Jeffrey, Anthony Favaloro, James Wolyncewicz, Grace et al.

Source: Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 12, p2301-2305. 5p.

Epstein–Barr Virus and Hepatitis E Virus in an Immunocompetent Adult: A Rare Case Report.

Authors: Attieh, Philippe Al Hazzouri, Antonio Karam, Karam et al.

Source: Clinical Case Reports. Feb2026, Vol. 14 Issue 2, p1-5. 5p.

Breast Implant–Associated Epstein–Barr Virus‐Positive Diffuse Large B‐Cell Lymphoma.

Authors: Maerten, Thibault Seijnhaeve, Elsa Bernard, Wivine et al.

Source: Case Reports in Hematology. 2/5/2026, Vol. 2026, p1-4. 4p.

Deutsche Bank Terminated Staff Over Epstein Ties, Sewing Says.

Authors: Comfort, Nicholas Heubeck, Nick

Source: Bloomberg.com. 5/28/2026, pN.PAG-N.PAG. 1p.

Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.

Authors: Sun, Yizhe Li, Shunji Mitra, Bidisha et al.

Source: PLoS Pathogens. 1/26/2026, Vol. 22 Issue 1, p1-27. 27p.

Cytokine Signatures Induced by Epstein-Barr Virus Antigens in Multiple Sclerosis: Elucidating the Role of B-Cell and T-Cell Hyperactivation in Disease Relapse.

Authors: Perrella, Alessandro Bellopede, Pasquale D'Antonio, Anna et al.

Source: Applied Sciences (2076-3417); Dec2025, Vol. 15 Issue 23, p12835, 10p

Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression.

Authors: Afrasiabi, Ali Bocking, Wade J. Schibeci, Stephen D. et al.

Source: Immunity, Inflammation & Disease. Mar2026, Vol. 14 Issue 3, p1-5. 5p.

Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122.

Authors: Chan, Anthony T. C. Lee, Victor Ho Fun Hong, Ruey‐Long et al.

Source: Cancer Medicine. Feb2026, Vol. 15 Issue 2, p1-9. 9p.